EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Upfront Surgery Versus Upfront Concurrent Chemoradiotherapy as Primary Modality in Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

Tsung-You Tsai, Wing-Keen Yap iD, Ting-Hao Wang, Yi-An Lu, Anna See, Yu-Feng Hu, Yenlin Huang, Huang-Kai Kao, Kai-Ping Chang iD

Journal of Otolaryngology - Head & Neck Surgery · 2024-01 · 53

DOI: 10.1177/19160216241293633 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Otolaryngology - Head & Neck Surgery, online erschienen am 28.10.2024. Verfasst von Tsung-You Tsai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Chemoradiotherapy, Hypopharyngeal Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council, Chang Gung Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The management of hypopharyngeal squamous cell carcinoma (HPSCC) continues to be one of the most formidable challenges in the realm of head and neck oncology.

Objectives

The aim of this meta-analysis was to evaluate the disparity in survival outcomes between upfront surgery and upfront concurrent chemoradiotherapy as the primary treatment modality in patients with HPSCC.

Design

Systemic review with meta-analysis.

Setting

The meta-analysis was conducted in strict accordance with the PRISMA guideline. A literature search through PubMed, EMBASE, and the Cochrane Library were conducted until January 2023. The adjusted hazard ratio (aHR) with 95% confidence intervals (CIs) of different survival outcomes were extracted and pooled.

Participants

Studies that incorporated HPSCC patients without receiving induction chemotherapy.

Interventions

Upfront surgery versus upfront concurrent chemoradiotherapy. Main Outcome Measures Overall survival (OS) and disease-free survival (DFS).

Results

Eight studies published between 2015 and 2023, with a pooled patient population of 1619, were included in this meta-analysis. The outcomes reveal that upfront surgery was notably linked with improved OS (aHR 0.66, 95% CI 0.57-0.78) and DFS (aHR 0.75, 95% CI 0.63-0.90). Subgroup analyses were conducted to investigate the impact of the overall stage of the tumor and the extent of surgery on OS. In patients with advanced HPSCC (stages III and IV), upfront surgery remained associated with better OS (aHR 0.65, 95% CI 0.56-0.77). Concerning the extent of surgery, both subgroups exhibited a superior OS outcome associated with upfront surgery (exclusive total laryngopharyngectomy group: aHR 0.54, 95% CI 0.39-0.75; total/partial laryngopharyngectomy group: aHR 0.71, 95% CI 0.59-0.84). Conclusions and Relevance The results demonstrated that upfront surgery showed better OS and DFS than concurrent chemoradiation and remind the clinicians of the potential reduction in survival outcomes when choosing concurrent chemoradiotherapy as primary treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChemoradiotherapyHypopharyngeal NeoplasmsSquamous Cell Carcinoma of Head and NeckHumansDisease-Free SurvivalSurvival Rate

Stichwörter der Autor:innen

CRTHPSCCchemoradiotherapyhypopharyngeal cancersquamous cell carcinomaupfront surgery

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Proton and Radiation Therapy Center, Chang Gung Memorial Hospital-Linkou Medical Center, Department of Radiation Oncology, Chang Gung University, Taoyuan, Taiwan.
  • College of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Department of Otorhinolaryngology Head and Neck Surgery, Singapore General Hospital, Singapore.
  • Department of Anatomic Pathology, Chang Gung Memorial Hospital at Linkou Branch, Taoyuan, Taiwan.
  • Institute of Stem Cell and Translation Cancer Research, Chang Gung Memorial Hospital at Linkou Branch, Taoyuan, Taiwan.

ORCID-Profile: Wing-Keen Yap, Kai-Ping Chang

Förderung

  • National Science and Technology Council
  • Chang Gung Medical Foundation

Zitieren

APA

Tsai, T. Y., Yap, W. K., Wang, T. H., Lu, Y. A., See, A., Hu, Y. F., Huang, Y., Kao, H. K., & Chang, K. P. (2024). Upfront Surgery Versus Upfront Concurrent Chemoradiotherapy as Primary Modality in Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Journal of Otolaryngology - Head & Neck Surgery, 53. https://doi.org/10.1177/19160216241293633

Vancouver

Tsai TY, Yap WK, Wang TH, Lu YA, See A, Hu YF, et al. Upfront Surgery Versus Upfront Concurrent Chemoradiotherapy as Primary Modality in Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Journal of Otolaryngology - Head & Neck Surgery. 2024;53. doi:10.1177/19160216241293633

BibTeX
@article{Tsai2024,
  author = {Tsai, Tsung-You and Yap, Wing-Keen and Wang, Ting-Hao and Lu, Yi-An and See, Anna and Hu, Yu-Feng and Huang, Yenlin and Kao, Huang-Kai and Chang, Kai-Ping},
  title = {Upfront Surgery Versus Upfront Concurrent Chemoradiotherapy as Primary Modality in Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis},
  journal = {Journal of Otolaryngology - Head & Neck Surgery},
  year = {2024},
  volume = {53},
  doi = {10.1177/19160216241293633}
}
Kostenlos starten →